95
Views
1
CrossRef citations to date
0
Altmetric
Guest editorial

Hormone replacement use and cardiovascular function and structure in postmenopausal women

, &
Pages 3-5 | Published online: 08 Jul 2009

References

  • Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 2000; 133:933–941.
  • Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med. 1999;130:545–553.
  • Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605–613.
  • Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, et al. HERS Research Group. Noncardiovascular disease outcomes during 6.8 years of hormone therapy. JAMA. 2002;288: 58–66.
  • Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002; 288:321–333.
  • The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative rando-mized controlled trial. JAMA. 2004;291:1701–1712.
  • Foster W, Lip GYH. Hormone replacement therapy and cardiovascular disease: Does route of administration and formulation matter? Br J Haematol. 2004;124:836–840.
  • Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105–1110.
  • Lip GYH, Felmeden DC. Hormone replacement therapy and cardiovascular risk: Do abnormalities of coagulation and fibrinolysis matter? J Intern Med. 2001;249:201–204.
  • Barret Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? JAMA. 1991;265:627–631.
  • Wong J, Wong S, Handa SP, Abbott EC. Hormone replacement use, arterial distensibility, cardiac structure and circadian blood pressure profile in menopausal women. Blood Press. 2005;14:12–20.
  • Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349:523–534.
  • Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497.
  • Pines A, Fisman EZ, Levo Y, Averbuch M, Lidor A, Drory Y, et al. The effects of hormone replacement therapy in normal postmenopausal women: Measurements of Doppler-derived parameters of aortic flow. Am J Obstet Gynecol. 1991; 164:806–812.
  • Gangar KF, Vyas S, Whitehead M. Pulsatility index in internal carotid artery in relation to transdermal estradiol and time since menopause. Lancet. 1991;338:839–842.
  • Volterrani M, Rosano G, Coats A, Beale C, Collins P. Estrogen acutely increases peripheral blood flow in post-menopausal women. Am J Med. 1995;99:119–122.
  • Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Acute vascular effects of estrogen in postmeno-pausal women. Circulation. 1994;90:786–791.
  • Samaan SA, Crawford MH. Estrogen and cardiovascular function after menopause. J Am Coll Cardiol. 1995;26:1403–1410.
  • Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, et al. Menopause is associated with endothelial dysfunction. Hypertension. 1996;28:576–582.
  • Fischer G, Swain M. Effect of sex hormones on blood pressure and vascular connective tissue in castrated and noncastrated male rats. Am J Physiol. 1977;232:H617–H621.
  • Edmunds E, Lip GYH. Cardiovascular risk in women: The cardiologist's perspective. Q J Med. 2000;93:135–145.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.